Featured Research

from universities, journals, and other organizations

Alzheimer's researchers creating 'designer tracker' to quantify elusive brain protein, provide earlier diagnosis

Date:
April 23, 2013
Source:
Ohio State University Center for Clinical and Translational Science
Summary:
Alzheimer's researchers know the disease is caused by toxic beta amyloid and tau lesions, yet, the recent failure of emerging therapies targeting these lesions suggest that successful treatments will require diagnosis of disease at its earliest stages. Now, by using computer-aided drug discovery, researchers are in the process of developing an imaging chemical that attaches predominantly to tau-bearing lesions in living brain, opening the door for earlier diagnosis – and better treatments for tau-involved conditions like Alzheimer’s, frontal temporal dementia and traumatic brain injuries.

One of the biggest challenges with Alzheimer's disease (AD) is that by the time physicians can detect behavioral changes, the disease has already begun its irreversibly destructive course. Scientists know toxic brain lesions created by amyloid beta and tau proteins are involved. Yet, emerging therapies targeting these lesions have failed in recent clinical trials. These findings suggest that successful treatments will require diagnosis of disease at its earliest stages.

Related Articles


Now, by using computer-aided drug discovery, an Ohio State University molecular biochemist and molecular imaging chemist are collaborating to create an imaging chemical that attaches predominantly to tau-bearing lesions in living brain. Their hope is that the "designer" tracer will open the door for earlier diagnosis -- and better treatments for Alzheimer's, frontal temporal dementia and traumatic brain injuries like those suffered by professional athletes, all conditions in which tangled tau filaments accumulate in brain tissue.

"We're creating agents that are specifically engineered to bind the surface of aggregated tau proteins so that we can see where and how much tau is collecting in the brain," said Jeff Kuret, professor of molecular and cellular biochemistry at The Ohio State University College of Medicine. "We think the "tau signature" can be used to improve diagnosis and staging of disease."

The study's co-investigator, Michael Tweedle, a professor of radiology at Ohio State's College of Medicine, notes that there may be more advantages to being able to image tau.

"Unlike beta amyloid, tau appears in specific brain regions in Alzheimer's," said Tweedle. "With a better view of how tau is distinct from amyloid, we'll be able to create a much more accurate view of disease staging, and do a much better job getting the right therapeutics into the right populations at the right time."

Tweedle notes that there are no drugs currently available that target tau, but that several are in development. Both investigators emphasized that being able to image tau in a living brain could be critical for identifying individuals that could benefit from tau-tackling drugs as they move into clinical trials.

The search for tau selective neuroimaging agents is proceeding with the help of a pilot grant awarded to the team by Ohio State's Center for Clinical and Translational Science (CCTS). The award provided them with the funds needed to synthesize candidate radiotracers for testing. The team then received funding from the Alzheimer's Drug Discovery Foundation to test how the compounds distribute throughout the body. This work also leverages several CCTS-funded core resources. So far, the team has prepared 12 ligands that have promising binding affinity for tau aggregates.

"It's an iterative process, and each step gives us new information on what we need to be looking for," said Tweedle. "Now we know what parts of the molecule to alter while trying to retain other good qualities."

Tauopathies are neurodegenerative diseases associated with the accumulation of tau protein "tangles" in the human brain. Alzheimer's disease is one of the most common tauopathies, but tau aggregates are also found in certain forms of frontal temporal dementia as well as traumatic brain injuries. Alzheimer's disease has become one of the most common disorders in the aging population, and is predicted to be a major driver of health care costs in the coming decades.


Story Source:

The above story is based on materials provided by Ohio State University Center for Clinical and Translational Science. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University Center for Clinical and Translational Science. "Alzheimer's researchers creating 'designer tracker' to quantify elusive brain protein, provide earlier diagnosis." ScienceDaily. ScienceDaily, 23 April 2013. <www.sciencedaily.com/releases/2013/04/130423102124.htm>.
Ohio State University Center for Clinical and Translational Science. (2013, April 23). Alzheimer's researchers creating 'designer tracker' to quantify elusive brain protein, provide earlier diagnosis. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2013/04/130423102124.htm
Ohio State University Center for Clinical and Translational Science. "Alzheimer's researchers creating 'designer tracker' to quantify elusive brain protein, provide earlier diagnosis." ScienceDaily. www.sciencedaily.com/releases/2013/04/130423102124.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Mind & Brain News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Milestone Birthdays Can Bring Existential Crisis, Study Says

Milestone Birthdays Can Bring Existential Crisis, Study Says

Newsy (Nov. 21, 2014) Researchers find that as people approach new decades in their lives they make bigger life decisions. Video provided by Newsy
Powered by NewsLook.com
5 Things You Didn't Know About Depression

5 Things You Didn't Know About Depression

Odyssey Networks (Nov. 21, 2014) According to a new survey by the National Alliance on Mental Illness, over 60% of Americans with a diagnosed mental illness believe their condition worsens around the holidays. Stress, high expectations and loneliness are contributing factors that contribute to the "holiday blues." Video provided by Odyssey
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins